Polymorphisms of the IL-1β and IL-1β-inducible genes in ulcerative colitis

Journal of Gastroenterology

Volumn 37, Issue SUPPL. 14, 2002, Pages 107-110

  Nohara, Hiroaki ^a   Saito, Yuki ^a   Higaki, Singo ^a   Okayama, Naoko ^a   Hamanaka, Yuichiro ^a   Okita, Kiwamu ^a   Hinoda, Yuji ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Il 1 ; MMP 1; MMP 3; Polymorphism ulcerative colitis

Indexed keywords

INTERLEUKIN 1; INTERSTITIAL COLLAGENASE; NITRIC OXIDE SYNTHASE; STROMELYSIN; INTERLEUKIN 1 RECEPTOR;

ADULT; ARTICLE; COLON RESECTION; COLONOSCOPY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULCERATIVE COLITIS; ADOLESCENT; ALLELE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; HOSPITALIZATION; INTESTINE MUCOSA; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; INTESTINAL MUCOSA; JAPAN; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, INTERLEUKIN-1; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036878245     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03326427     Document Type: Article

References (18)

1. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's dease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:900-6.
2. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-8.
3. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
4. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature (Lond) 2000;404:398-402.
5. von Lampe B, Barthel B, Coupland SE, Riecken E-O, Rosewicz SS. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000;47:63-73.
6. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 2000;19:175-7.
7. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the stromelysin gene 5A/6A. Atherosclerosis 2000;151:587-9.
8. Perner A, Rask-Madsen J. The potential role of nitric oxide in chronic inflammatory bowel disease. Aliment Pharmacol Ther 1999;13:135-44.
9. Weiming Xu, Lizhi Liu, Emson PC, Harrington CR, Charles IG. Evolution of a homopurine-homopyrimidine pentanucleotide repeat sequence upstream of the human inducible nitric oxide synthase gene. Gene (Amst) 1997;204:165-70.
10. Santtila A, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998;47: 195-8.
11. Stokkers PCF, van Aken BE, Basoski N, Reitsma PH, Tytgat GNJ, van Deventer SJH. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998;43: 33-9.
12. Nemetz A, Kope A, Molnar T, Kovacs A, Feher J, Tulassay Z, et al. Significant differencs in the interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J Gastroenterol 1999;2:175-9.
13. Mwantembe O, Gaillard MC, Barkhuizen M, Pillay V, Berry SD, Dewar JB, et al. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. Immunogenetics 2001;52:249-54.
14. Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, et al. Significance of interleukin-1 beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997;92:1164-9.
15. Nemetz A, Nosti-Escanilla MP, Molnar T, Kope A, Kovacs A, Feher J, et al. IL-1β gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999;49: 527-31.
16. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease. Genes Immun 2001;2:61-70.
17. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J, et al. Taq I polymorphisms in the human interleukin-1beta (IL-1beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invesetig 1992;22:396-402.
18. Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, et al. Clinical, biological, and histological parameters as predictors of relapse in ulcerative colitis. Gatroenterology 2001;120:13-20.